Literature DB >> 512366

C3b binding immune complexes and immunoconglutinins in human sera. Detection by enzyme-linked immunosorbent assay (ELISA).

A Hautanen, E Linder.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) designed to measure autoantibodies against C3b (immunoconglutinins: IK) also detects immune complexes (IC). Solid phase C3b, in addition to binding IK of IgG, IgM and IgA classes, bound aggregated human IgG, IgA and aggregated immunologically purified anti-tetanus toxid antibodies as well as model complexes of tetanus toxoid-human anti-toxoid. Significant C3b binding IgG, IgM and IgA activities were seen in the sera of 20 SLE patients but not in sera from healthy blood donors. Ultracentrifugation analysis of two SLE sera revealed C3b binding IgG and IgA activities in both light (7S) and heavy (greater than or equal to 11S) fractions. This indicates simultaneous presence of IK and IC in these sera. On the basis of the known relationship between IK and IC formation we suggest that the solid phase C3b ELISA may be of value in evaluating immune reactions in patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512366     DOI: 10.1016/0022-1759(79)90019-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Circulating heavy IgM in IgM nephropathy.

Authors:  S O Disciullo; J G Abuelo; K Moalli; J C Pezzullo
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

2.  Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits.

Authors:  G D Harkiss; D L Brown
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

3.  Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.

Authors:  T Hidvégi; G Füst; E Rajnavölgyi; J Kulics; J Gergely
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

4.  Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Helena Tyden; Christian Lood
Journal:  Arthritis Res Ther       Date:  2020-05-29       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.